Investors

Midatech Pharma PLC (dual listed on LSE AIM: MTPH; and NASDAQ: MTP) is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines.

Shareholder Information

Date Title Document
08/12/20 Notice of 2020 AGM Download
12/02/20 Shareholder Circular and Notice of General Meeting to be held on 2 March 20 Download
19/06/19 Notice of 2019 AGM Download
05/02/19 Shareholder Circular, Open Offer & Notice of General Meeting Panel Waiver Download
28/09/18 Shareholder Circular and Notice of General Meeting to be held on 15 October 18 Download
13/08/18 Notice of 2018 AGM Download
28/09/17 Notice of General Meeting to be held on 16 October 2017 Download
11/04/17 Notice of Annual General Meeting 2017 Download
12/10/16 Notice of General Meeting to be held on 28 October 2016 Download
11/05/16 Notice of 2016 AGM Download
21/05/15 Notice of 2015 AGM Download

Share Detail

Number of shares 63,073,852
Country of listing UK / US
Status AIM Listed / NASDAQ Listed
Index FTSE AIM All Share / NASDAQ
FTSE Sector Pharmaceutical & Biotechnology
FTSE sub-sector Biotechnology
Ticker MTPH / MTP
CUSIP GB00BKT14T00

The percentage of 0.1p Ordinary shares not being held in public hands is 17%

Shares held in treasury: Nil.

There are no restrictions on the transfer of Ordinary shares in the Company.

Information correct as at 10 December 2020.

Major Shareholders

Midatech Pharma has been notified or is aware of the following holdings of more than 3% or more of the issued share capital of the Company.

Name Number of shares %
CMS Medical Venture Investment (HK) Limited* 5,194,805 8.2
A&B (HK) Company Limited* 5,194,805 8.2
Lombard Odier Asset Management (Europe) Limited 5,555,556 8.8

* CMS Medical Venture Investment (HK) Limited and A&B (HK) Company Limited are considered a Concert Party

Information correct as at 10 December 2020.

ADR Information

Ticker Structure Exchange Ratio DR ISIN CUSIP
MTP Level III ADR NASDAQ 1 ADR : 5 Ordinary Shares US59564R3021 59564R302